Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,360.00
+290.00 (3.59%)
Sep 1, 2026, 3:30 PM KST

Chabiotech Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,311,3541,268,2541,045,049953,951844,583727,476
Revenue Growth
13.93%21.36%9.55%12.95%16.10%9.44%
Gross Profit
362,131354,197269,824271,016201,025213,498
Operating Income
-82,554-57,147-59,975-9,425-53,6696,397
Net Income
14,272-109,876-4,764-8,431-47,543-13,968
Earnings Per Share
135.82-1649.00-150.00-149.80-845.00-256.29
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
364,236339,225353,501221,789250,627343,527
Total Debt
815,347905,433825,938449,635400,860341,190
Net Cash (Debt)
-451,110-566,207-472,437-227,846-150,2332,337
Net Cash Growth
------93.49%
Net Cash Per Share
-4331.39-8435.60-14876.43-3992.36-2670.0242.88

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-100,516-72,104-48,24413,018-19,39926,248
Capital Expenditures
-182,603-146,985-93,947-70,365-120,355-112,598
Free Cash Flow
-283,120-219,089-142,191-57,346-139,754-86,350
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.62%27.93%25.82%28.41%23.80%29.35%
Operating Margin
-6.30%-4.51%-5.74%-0.99%-6.35%0.88%
Pretax Margin
0.28%-11.30%-0.28%0.33%-8.44%-1.38%
Profit Margin
1.09%-8.66%-0.46%-0.88%-5.63%-1.92%
FCF Margin
-21.59%-17.27%-13.61%-6.01%-16.55%-11.87%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-44.0344.0344.0344.0344.03
PS Ratio
0.570.880.611.160.871.54